laboratori corpor
cut estim price target follow morn revis
outlook tie primarili softer expect lab volum covanc guidanc
unchang slower growth refer dtc genet test
lower hospit health system referr softer volum current
exclus contract open network
key reason shortfal lower guidanc disappoint
carri challeng pama head wind exclus open network
dynam lower hospital/health system referr bear watch think
increment pama pressur like drive share gain opportun
acceler potenti final patient increasingli spend
money payor focu valu lh enviabl posit scale low-cost
high qualiti provid grow appar compani invest
conveni qualiti like increas differenti cut
ep
tie conserv assumpt diagnost segment
also cut price target reflect lower assum multipl
vs prior new estim
tr target
laboratori corpor america hold
laboratori corpor america mm
servic
revenu
incom equiti invest
revenu
page
laboratori corpor america hold
headquart burlington nc laboratori corpor america hold labcorp one
largest independ clinic laboratori broad offer includ routin test
blood chemistri urinalys pap hiv substance-abus etc specialti test oncolog hiv
genotyp phenotyp diagnost genet clinic research trial compani also
opper cro busi extend servic offer includ clinic research provid
meaning intern presenc recent chiltern acquisit expand cro servic
clinic lab remain integr part healthcar deliveri model diagnost test critic
compon treatment decis process combin covanc busi lh boast
signific scale divers servic offer uniqu posit area person medicin
potenti risk-bas reimburs system diversifi revenu stream custom
base also meaning lower reimburs risk one custom repres revenu
govern pay addit signific clinic horsepow geograph
diversif provid platform addit growth opportun time
valuat risk
price target base stock trade adjust ep slight premium
current multipl industri peer hold given labcorp sizabl esoter presenc
solid cash flow gener attract cross-sel opportun covance/chiltern view
appropri addit believ effici initi aggress focu cost
control could provid support risk rate price target includ advers shift
reimburs pama poor integr acquisit pressur econom uncertainti
perform covanc increas competit
compani mention note
david macdonald herebi certifi view express research report accur reflect
person view subject compani secur also certifi
receiv direct indirect compens exchang express
specif recommend report
